For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Dexcom G7 (real-time continuous glucose monitoring) - Type II Diabetes (Children and Young People)
PAD Profile : Dexcom G7 (real-time continuous glucose monitoring) - Type II Diabetes (Children and Young People)
Traffic Light Status
Status 1 of 1.
- Device
Guidelines
No guidelines returned.
Other Drugs
- Detection Sensor Interstitial Fluid/Gluc
- Detection Sensor Interstitial Fluid/Gluc
- Detection Sensor Interstitial Fluid/Gluc
- Detection Sensor Interstitial Fluid/Gluc
- Detection Sensor Interstitial Fluid/Gluc
- Detection Sensor Interstitial Fluid/Gluc
- Detection Sensor Interstitial Fluid/Gluc
- Detection Sensor Interstitial Fluid/Gluc
- Detection Sensor Interstitial Fluid/Gluc
Other Indications
- Type II Diabetes (Children and Young People)
- Congenital hyperinsulinism
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type II Diabetes (Children and Young People)
- Type I Diabetes
- Type I Diabetes
- Type II Diabetes (Children and Young People)
Additional Documents
No additional documents returned.
Committee Recommendations
The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed that real time Continuous Glucose Monitoring (rtCGM) or intermittently scanned Continuous Glucose Monitoring (isCGM) is offered to children and young people with type II diabetes in line NG18 Diabetes (type 1 and type 2) in children and young people: diagnosis and management).
CGM devices have been given the following traffic light status:
RED traffic light status
Initiation and continued supplies will be through the specialist diabetes service
- Freestyle Libre 3 (rtCGM)
- Dexcom G7 (rtCGM)
BLUE traffic light status (with an information sheet)
Initiation will be by the diabetes specialist service, who will provide the first 28 days of treatment (and capillary test strips if required), prior to transfer of care to primary care.
- Freestyle Libre 2 (isCGM)
- Dexcom One (rtCGM)
Use the flow chart to ensure the most appropriate and cost-effective CGM devices are used to meet patient need